(Q33494570)

27 July 2017

title

A phase II study of carboplatin and cyclophosphamide in advanced ovarian carcinoma (English)

1 reference

27 July 2017

1 reference

1 reference

Martoni A

1

1 reference

27 July 2017

Panetta A

2

1 reference

27 July 2017

Angelelli B

3

1 reference

27 July 2017

Melotti B

4

1 reference

27 July 2017

Pannuti F

5

1 reference

27 July 2017

publication date

1 February 1993

1 reference

27 July 2017

published in

Journal of Chemotherapy

1 reference

27 July 2017

volume

5

1 reference

27 July 2017

issue

1

1 reference

27 July 2017

page(s)

47-51

1 reference

Randomized trial comparing two combination chemotherapy regimens (CHAP-5 v CP) in advanced ovarian carcinoma

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739209

Carboplatin: the clinical spectrum to date

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739209

Randomized trial in advanced ovarian cancer comparing cisplatin and carboplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739209

Reporting results of cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739209

Four-year analysis of platinum and anthracycline combination for ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739209

Cyclophosphamide-cisplatin versus cyclophosphamide-carboplatin in stage III-IV ovarian carcinoma: a comparison of equally myelosuppressive regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739209

Carboplatin and cyclophosphamide salvage therapy for ovarian cancer patients relapsing after cisplatin combination chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739209

10.1080/1120009X.1993.11739209

21 January 2018

Identifiers

DOI

1 reference

27 July 2017

1 reference